Csenge Advisory Group Acquires 121,363 Shares of Axon Enterprise, Inc $AXON

Csenge Advisory Group lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 10,535.0% during the third quarter, HoldingsChannel.com reports. The fund owned 122,515 shares of the biotechnology company’s stock after purchasing an additional 121,363 shares during the quarter. Axon Enterprise makes up 2.0% of Csenge Advisory Group’s holdings, making the stock its 8th largest position. Csenge Advisory Group’s holdings in Axon Enterprise were worth $51,765,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the business. State Street Corp boosted its stake in Axon Enterprise by 5,700.2% during the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after purchasing an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. grew its position in Axon Enterprise by 18,050.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock worth $7,400,094,000 after purchasing an additional 13,127,348 shares during the last quarter. BlackRock Inc. increased its stake in Axon Enterprise by 4.3% in the second quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock valued at $4,672,432,000 after purchasing an additional 345,365 shares during the period. Robeco Institutional Asset Management B.V. increased its stake in Axon Enterprise by 391,214.9% in the third quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock valued at $2,952,943,000 after purchasing an additional 6,987,098 shares during the period. Finally, The Manufacturers Life Insurance Company raised its holdings in shares of Axon Enterprise by 8,432.6% in the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after buying an additional 3,496,493 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Isaiah Fields sold 1,017 shares of the stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the transaction, the insider directly owned 56,264 shares of the company’s stock, valued at approximately $27,032,038.80. This represents a 1.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider directly owned 97,761 shares of the company’s stock, valued at $61,266,818.70. This represents a 8.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 37,397 shares of company stock valued at $21,234,034. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise Trading Down 0.2%

NASDAQ AXON opened at $302.54 on Wednesday. The stock has a market capitalization of $24.64 billion, a P/E ratio of 96.97, a P/E/G ratio of 5.76 and a beta of 1.48. Axon Enterprise, Inc has a 52-week low of $291.45 and a 52-week high of $665.07. The firm has a 50-day moving average price of $430.30 and a 200 day moving average price of $472.14. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The firm had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same quarter in the previous year, the business earned $1.17 EPS. Axon Enterprise’s revenue for the quarter was up 27.8% on a year-over-year basis. Equities research analysts expect that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will become its U.S. public-safety distributor. The deal could broaden Axon’s public-safety technology offering, though its scale also brings investment and execution risks. Axon invests in Skydio
• Positive Sentiment: West Fargo police plan to replace Flock technology with Axon’s system, including new AI features—an example of continued adoption by public-safety customers. West Fargo police adoption
• Positive Sentiment: Despite lowering its price target, Barclays retained an “overweight” rating at $507; Northland reportedly still sees a $540 target after the stock’s steep fall from its August high. These views suggest some analysts see substantial recovery potential, though targets are not guarantees. Northland target outlook
• Neutral Sentiment: A short-interest report lists 0 shares short, despite describing a large increase. The figure appears inconsistent and does not provide a reliable indication of short-selling pressure.
• Negative Sentiment: Axon’s third-quarter adjusted EPS of $1.72 and revenue of about $909 million fell short of estimates. Cautious guidance and roughly $130 million in federal-contract revenue shifting out of 2026 have weighed on the outlook; shares have fallen sharply since the results, while Motorola rose after its earnings beat. Axon versus Motorola after earnings
• Negative Sentiment: Law firms announced investigations into potential securities-law violations. These are allegations under investigation, not findings of wrongdoing, but may add legal and reputational uncertainty for investors. Axon securities investigation notice

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Morgan Stanley increased their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Needham & Company LLC dropped their price target on Axon Enterprise from $750.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday, November 6th. UBS Group boosted their price target on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Argus upped their price objective on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, September 3rd. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $612.18.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.